Using the industry peer median P/E Multiples multiple (trailing + forward), Abrdn Healthcare Investors (HQH) has a fair value of $20.56 based on 9 comparable companies in the Asset Management industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing P/E | Forward P/E | |
|---|---|---|---|
| Abrdn Healthcare InvestorsHQH | 1,075 | 10.9x | — |
| Trinity Capital Inc. | 1,179 | 8.7x | 8.1x |
| MidCap Financial Investment Corporation | 1,077 | 17.2x | 6.8x |
| Kayne Anderson BDC, Inc. | 988 | 11.2x | 7.2x |
| Virtus Investment Partners, Inc. | 949 | 7.1x | 5.4x |
| PennantPark Floating Rate Capital Ltd. | 888 | 12.4x | 7.0x |
| Bain Capital Specialty Finance, Inc. | 886 | 9.0x | 6.7x |
| P10, Inc. | 830 | 0.5x | — |
| Carlyle Secured Lending, Inc. | 808 | 11.4x | 5.8x |
| New Mountain Finance Corporation | 782 | 59.1x | 5.9x |
| Industry Median | 11.2x | 6.7x | |
| (*) Profit after tax | 99 | ||
| Equity Value | 1,103 | ||
| (/) Outstanding shares | 54 | ||
| Fair Price | $21 | ||
Using the industry peer median EV/EBITDA multiple (trailing + forward), Abrdn Healthcare Investors (HQH) has a fair value of $22.34 based on 9 comparable companies in the Asset Management industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/EBITDA | Forward EV/EBITDA | |
|---|---|---|---|
| Abrdn Healthcare InvestorsHQH | 1,075 | 10.9x | — |
| Trinity Capital Inc. | 1,179 | 11.4x | 11.5x |
| MidCap Financial Investment Corporation | 1,077 | 15.6x | 14.0x |
| Kayne Anderson BDC, Inc. | 988 | 12.2x | 14.7x |
| Virtus Investment Partners, Inc. | 949 | 8.1x | 8.2x |
| PennantPark Floating Rate Capital Ltd. | 888 | 37.7x | 35.3x |
| Bain Capital Specialty Finance, Inc. | 886 | 12.6x | 10.5x |
| P10, Inc. | 830 | 1.7x | — |
| Carlyle Secured Lending, Inc. | 808 | 13.7x | 12.7x |
| New Mountain Finance Corporation | 782 | 7.8x | 7.7x |
| Industry Median | 12.2x | 12.1x | |
| (*) EBITDA | 99 | ||
| = Enterprise Value | 1,198 | ||
| (-) Net Debt | -0 | ||
| Equity Value | 1,198 | ||
| (/) Outstanding shares | 54 | ||
| Fair Price | $22 | ||
Using the industry peer median EV/Revenue multiple (trailing + forward), Abrdn Healthcare Investors (HQH) has a fair value of $18.84 based on 10 comparable companies in the Asset Management industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| Abrdn Healthcare InvestorsHQH | 1,075 | 10.8x | — |
| Trinity Capital Inc. | 1,179 | 10.6x | 10.7x |
| MidCap Financial Investment Corporation | 1,077 | 10.8x | 9.7x |
| Kayne Anderson BDC, Inc. | 988 | 8.8x | 10.7x |
| Virtus Investment Partners, Inc. | 949 | 4.0x | 4.0x |
| PennantPark Floating Rate Capital Ltd. | 888 | 14.8x | 13.9x |
| Bain Capital Specialty Finance, Inc. | 886 | 9.6x | 8.0x |
| P10, Inc. | 830 | 0.7x | 87.8x |
| Carlyle Secured Lending, Inc. | 808 | 11.4x | 10.6x |
| New Mountain Finance Corporation | 782 | 6.4x | 6.3x |
| Horizon Technology Finance Corporation | 200 | 14.2x | 6.0x |
| Industry Median | 10.1x | 10.1x | |
| (*) Revenue | 100 | ||
| = Enterprise Value | 1,011 | ||
| (-) Net Debt | -0 | ||
| Equity Value | 1,011 | ||
| (/) Outstanding shares | 54 | ||
| Fair Price | $19 | ||
Using the PEG framework with historical EPS growth of 8.0%, the company has a fair value of $14.72 based on TTM EPS (FY2025) of $1.84.
| EPS Growth RateHistorical | -14.8% |
| Adjusted Growth (clamped 8–25%)Clamped | 8.0% |
| Fair P/E | 8.0x |
| TTM EPS (FY2025) | $1.84 |
| Fair Value | $14.72 |
No analyst estimates available.
| Year | Net Income | EPS | YoY |
|---|---|---|---|
| FY2021 | $155.2M | $3.49 | — |
| FY2022 | $-194.2M | $-4.10 | -217.5% |
| FY2023 | $56.3M | $1.14 | — |
| FY2024 | $184.9M | $3.55 | +211.4% |
| FY2025 | $98.6M | $1.84 | -48.2% |
4Y Historical EPS CAGR: -14.8%
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.